Rockwell Medical names Heather Hunter as chief operating officer

WIXOM, Mich. - Rockwell Medical, Inc. (NASDAQ:RMTI), currently trading at $1.27 with a market capitalization of $44 million, announced Tuesday the promotion of Heather Hunter to Chief Operating Officer. Hunter, who joined the company in August 2022 as SVP, Chief Corporate Affairs Officer, will continue to report to President and CEO Dr. Mark Strobeck.

In her new role, Hunter will focus on modernizing infrastructure, implementing operational efficiencies, and aligning execution with the company’s strategic priorities, according to the press release.

Hunter initially joined Rockwell Medical to revitalize investor relations, corporate communications, and brand reputation. She later assumed responsibility for information technology and transportation.

"Formalizing a role dedicated to driving operational excellence, efficiencies, and scalability demonstrates our continued commitment to building a high-performing, highly efficient organization," said Strobeck in the announcement.

Hunter brings over two decades of experience to the position. Prior to Rockwell Medical, she served as Vice President, Communications and Corporate Affairs at Venatorx Pharmaceuticals, and held vice president positions at Safeguard Scientifics and W.P. Carey. She holds a B.A. in History from Yale University.

Rockwell Medical develops, manufactures, and distributes hemodialysis products for dialysis providers worldwide. The company describes itself as the leading supplier of liquid bicarbonate concentrates and the second largest supplier of acid and dry bicarbonate concentrates for dialysis patients in the United States.

The company was certified as a Great Place to Work in 2023, 2024 and 2025, and was named to Fortune’s Best Workplaces in Manufacturing & Production in 2024.

In other recent news, Rockwell Medical, Inc. reported its second-quarter earnings for 2025, revealing a mixed financial performance. The company’s earnings per share (EPS) exceeded expectations, with a smaller-than-anticipated loss of $0.01 per share compared to a projected loss of $0.05. However, its revenue did not meet forecasts, totaling $16.1 million against the expected $16.33 million. In leadership updates, Rockwell Medical announced the promotion of Heather Hunter to Chief Operating Officer. Hunter, who has been with the company since August 2022, previously served as Senior Vice President and Chief Corporate Affairs Officer. Her promotion was confirmed through a recent SEC filing, and she will continue reporting to Dr. Mark Strobeck, the company’s President and CEO. Prior to joining Rockwell Medical, Hunter held key roles at Venatorx Pharmaceuticals, Safeguard Scientifics, and W.P. Carey. These developments mark significant updates for Rockwell Medical.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.